Shineco announced that its subsidiary, Fuzhou Meida Health Management, has entered into Distribution Agreements for its water-soluble phospholipid concentrate health food beverage with a projected goal of more than $30 million in sales with six distribution companies, for a term of three years. Jennifer Zhan, CEO of Shineco, said, “The Company’s sustained research and development efforts have developed a production process that is expected to open up a potentially vast new market for our health food beverage. We believe that our technologically advanced production process provides a competitive advantage in the marketplace since it achieves a pure physical separation and extraction of the naturally active phospholipids.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SISI:
- Shineco Announces New Distribution Agreements for over $30 Million in Sales for its New Health Food Beverage
- Shineco regains compliance with Nasdaq minimum bid price rule
- Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Shineco enters into securities purchase agreement for gross proceeds of $7M
- Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of $7.0 Million
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue